ZDHHC11B Inhibitors

ZDHHC11B inhibitors function by targeting and manipulating the biochemical processes that this protein is involved in. Those that resemble the enzyme's natural substrates, such as fatty acid analogs, can compete with endogenous substrates for the active site of the enzyme, potentially saturating it and therefore decreasing its functional activity. Other compounds achieve inhibition by modifying the availability of substrates necessary for ZDHHC11B's palmitoylation activity, either by inhibiting enzymes responsible for substrate synthesis or by altering lipid metabolism, which can lead to a reduced supply of palmitoyl-CoA. Changes in cellular lipid composition, induced by specific lipid modulators, can also affect the membrane microdomains where ZDHHC11B exerts its function, leading to suboptimal enzyme activity. Additionally, inhibitors that affect protein trafficking can indirectly inhibit ZDHHC11B by disrupting the proper localization of either itself or its protein substrates to the necessary cellular compartments for palmitoylation.

Furthermore, some compounds may utilize redox mechanisms to modulate the activity of ZDHHC11B by inducing post-translational modifications, such as the S-nitrosylation of cysteine residues. This could result in the alteration of the enzyme's catalytic activity. In parallel, inhibitors that interfere with the prenylation and localization of proteins within the same pathway as ZDHHC11B can indirectly influence its function. Compounds that increase intracellular calcium concentrations could inhibit ZDHHC11B's activity as well, considering the potential impact on calcium-dependent enzymes and processes.